News · 26 weeks28-33%
2026-04-192026-10-11
Mix1490d
- Insider6(43%)
- SEC Filings4(29%)
- Earnings1(7%)
- Analyst1(7%)
- Other1(7%)
- Dividends1(7%)
Latest news
25 items- SECSEC Form S-8 filed by LifeMD Inc.S-8 - LifeMD, Inc. (0000948320) (Filer)
- PRLifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockNEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care and pharmacy services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ:LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on October 15, 2026, to holders of record at the close of business on October 2, 2026. About LifeMD, Inc. LifeMD® is a leading virtual care company making high-quality healthcare more accessible, convenient, and affordable. Through its vertically integrated platform, LifeMD connects patients with a 50-state affiliate
- SECLifeMD Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - LifeMD, Inc. (0000948320) (Filer)
- PRAT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMDDALLAS, Sept. 15, 2026 /CNW/ -- Through an exclusive collaboration with LifeMD, eligible AT&T wireless and fiber customers receive a complimentary LifeMD membership, a $228 annual value, with on-demand access to a nationwide virtual care and pharmacy platform.Key Takeaways:More than 100 million eligible AT&T wireless and fiber customers will receive complimentary access to LifeMD's virtual care and pharmacy platform.The $19-per-month LifeMD membership fee will be fully waived, a value of $228 per year.1Members can connect with providers for everyday health needs and prescriptions, with many medications shipped directly from Lif
- ANALYSTB. Riley Securities resumed coverage on LifeMD with a new price targetB. Riley Securities resumed coverage of LifeMD with a rating of Buy and set a new price target of $8.00
- INSIDERDirector Larovere Joan was granted 35,000 shares, increasing direct ownership by 33% to 142,050 units (SEC Form 4)4 - LifeMD, Inc. (0000948320) (Issuer)
- INSIDERDirector Strawn John R Jr was granted 85,000 shares, increasing direct ownership by 21% to 498,001 units (SEC Form 4)4 - LifeMD, Inc. (0000948320) (Issuer)
- INSIDERDirector Ditrolio Joseph was granted 35,000 shares, increasing direct ownership by 13% to 308,413 units (SEC Form 4)4 - LifeMD, Inc. (0000948320) (Issuer)
- INSIDERAmendment: Director Simon Roberto was granted 80,810 shares, increasing direct ownership by 81% to 180,810 units (SEC Form 4)4/A - LifeMD, Inc. (0000948320) (Issuer)
- INSIDERDirector Simon Roberto was granted 85,000 shares, increasing direct ownership by 42% to 288,175 units (SEC Form 4)4 - LifeMD, Inc. (0000948320) (Issuer)
- INSIDERDirector Macrae Calum Archibald was granted 35,000 shares, increasing direct ownership by 90% to 73,865 units (SEC Form 4)4 - LifeMD, Inc. (0000948320) (Issuer)
- SECSEC Form 10-Q filed by LifeMD Inc.10-Q - LifeMD, Inc. (0000948320) (Filer)
- SECLifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - LifeMD, Inc. (0000948320) (Filer)
- PRLifeMD to Report Second Quarter 2026 Financial Results on August 5NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on August 5, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Wednesday, August 5thTime:4:30 p.m. Eastern timeToll-Free Dial-In:(800) 715-9871International Dial-In:+1 (646) 307-1963Conference ID:3616168 ("LifeMD, Inc. Second Quarter 2026 Results")Live & Archived Webcast:Link Participants may also use the "Dial-Me In" option by visiting this link and entering
- PRLifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockNEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ:LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women's health, w
- SECLifeMD Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - LifeMD, Inc. (0000948320) (Filer)
- PRLifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) InjectionLandmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July 2026 in 37 states Companies to collaborate on consumer education and promotional initiatives to expand awareness of hypogonadism and convenient, transparent access to FDA-approved treatment NEW YORK and SAN DIEGO, June 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care and specialty care today announced a strategic co-marketing collaboration supporting a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate)
- INSIDERChief Technology Officer Sripad Umesh was granted 75,000 shares (SEC Form 4)4 - LifeMD, Inc. (0000948320) (Issuer)
- INSIDERSEC Form 3 filed by new insider Sripad Umesh3 - LifeMD, Inc. (0000948320) (Issuer)
- PRLifeMD Appoints Umesh Sripad as Chief Technology OfficerNEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Umesh Sripad as Chief Technology Officer (CTO), effective immediately. In this role, Mr. Sripad will lead LifeMD's technology strategy, platform transformation, AI enablement, cybersecurity, data infrastructure, and enterprise scalability initiatives as the company continues its rapid expansion. "Over the past five years, LifeMD has grown from a small men's virtual pharmacy platform into a 50-state virtual primary, specialty care, and pharmacy platform that serves nearly 350,000 patients," said Justin Schreiber, Chairman & Chief Executi
- PRLifeMD to Participate in Upcoming Investor ConferencesNEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming investor conferences. LD Micro Invitational XVI Conference, May 17 - 19, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles. Management will deliver a company presentation on Tuesday, May 19th at 9:00 a.m. Pacific time and will be available for one-on-one meetings. Investors can register for the conference here.B. Riley Securities 26th Annual Investor Conference, May 20 - 21, 2026, in Marina del Rey, Calif. Management will be holding one-on-one meetings on Wednesday, May 20th. Investors can re
- INSIDERChief Financial Officer Kavthekar Atul was granted 337,500 shares (SEC Form 4)4 - LifeMD, Inc. (0000948320) (Issuer)
- SECSEC Form 10-Q filed by LifeMD Inc.10-Q - LifeMD, Inc. (0000948320) (Filer)
- SECLifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - LifeMD, Inc. (0000948320) (Filer)
- SECSEC Form DEFA14A filed by LifeMD Inc.DEFA14A - LifeMD, Inc. (0000948320) (Filer)
LFMD FAQ
6 questionsWhat does LifeMD Inc. do?
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other...Where does LFMD stock trade?
LifeMD Inc. (LFMD) is listed on NASDAQ.What sector and industry is LFMD in?
LifeMD Inc. operates in the Health Care sector, Medical/Nursing Services industry.What are analysts saying about LFMD?
LifeMD Inc. has had 8 recent analyst actions on file. The most recent action was from B. Riley Securities: Buy with a $800.00 price target on 2026-09-11. Recent price targets range from $700.00 to $1800.00.What companies are similar to LFMD?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), HIMS (Hims & Hers Health Inc.), CHE (Chemed Corp), LFST (LifeStance Health Group Inc.), OPCH (Option Care Health Inc.). Compare LFMD side-by-side with any of them on Quantisnow.How can I track LFMD on Quantisnow?
Quantisnow aggregates LifeMD Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LFMD to receive live email and push alerts on every new disclosure.